NewsBenzingaAnixa Biosciences: la dichiarazione Form 4 mostra che l’amministratore delegato Amit Kumar segnala l’acquisto sul mercato aperto di 5.000 azioni ordinarie il 30 ottobre a un prezzo medio di 3,17 dollari per azione Anixa Biosciences: la dichiarazione Form 4 mostra che l’amministratore delegato Amit Kumar segnala l’acquisto sul mercato aperto di 5.000 azioni ordinarie il 30 ottobre a un prezzo medio di 3,17 dollari per azione Benzinga 2026.11.02 14:05 (GMT+0) Open on Benzinga Other news Keybanc Reiterates Sector Weight on NVIDIAto Sector Weight Top 3 Tech Stocks That May Fall Off A Cliff This Month Truist Securities Maintains Hold on BILL Holdings, Raises Price Target to $66 Nvidia’s China Exit Could Trigger a Bull-Bear Showdown: 6 Leveraged ETFs to Watch Wednesday OTraces Selects Labcorp To Perform Reference Laboratory Testing For Florida Department Of Health–Funded Clinical Trial Evaluating OTraces Blood-Based Prostate Cancer Diagnostic Platform Quanterix Affirms FY2026 Sales Guidance of $142.000M-$146.000M vs $143.357M Est
OTraces Selects Labcorp To Perform Reference Laboratory Testing For Florida Department Of Health–Funded Clinical Trial Evaluating OTraces Blood-Based Prostate Cancer Diagnostic Platform